BTIG Maintains Buy on Progyny, Raises Price Target to $40
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $40.
BTIG analyst David Larsen maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $30 to $40.